Author
Home > Health > What is the Difference Between MDR and XDR-TB?

Guilherme Mazui

•3 minutes to read

What is the Difference Between MDR and XDR-TB?

🆚 Go to Comparative Table 🆚

The main difference between multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) lies in the level of resistance to anti-TB drugs. Here are the key differences:

  • Multidrug-Resistant TB (MDR-TB): MDR-TB is caused by TB bacteria that are resistant to at least isoniazid and rifampin, the two most potent TB drugs. This means that the standard first-line treatment for TB is not effective against MDR-TB.
  • Extensively Drug-Resistant TB (XDR-TB): XDR-TB is a rare type of MDR-TB that is resistant to isoniazid, rifampin, a fluoroquinolone, and at least one of three injectable second-line drugs (amikacin, kanamycin, or capreomycin). In some cases, XDR-TB can also be resistant to bedaquiline or linezolid. This means that XDR-TB is resistant to the most potent TB drugs, leaving patients with treatment options that are much less effective.

Both MDR-TB and XDR-TB are more difficult to treat compared to drug-susceptible TB. They require longer treatment durations and come with potentially life-threatening side effects. XDR-TB is especially concerning, as it is more resistant to a larger range of drugs, making treatment even more challenging.

On this page
  • What is the Difference Between MDR and XDR-TB?
  • Comparative Table: MDR vs XDR-TB

    • Comparative Table: MDR vs XDR-TB

    Here is a table comparing the differences between MDR-TB (Multidrug-Resistant Tuberculosis) and XDR-TB (Extensively Drug-Resistant Tuberculosis):

    Feature MDR-TB XDR-TB
    Definition Resistant to at least isoniazid and rifampicin Resistant to at least isoniazid, rifampicin, and any fluoroquinolone, and at least one of the injectable drugs (i.e., amikacin, kanamycin, or capreomycin)
    Treatment Longer treatment duration than ordinary TB, but can still be treated with second-line drugs Resistant to both first- and second-line drugs, making treatment more difficult and prolonged
    Cure Rate Lower than ordinary TB, but still curable with proper treatment Practically incurable by standard first-line treatment, but can still be treated with second-line drugs
    Diagnosis Detected through drug-susceptibility testing (DST) Detected through drug-susceptibility testing (DST), with newer molecular methods providing results within hours
    Prevalence Higher than ordinary TB, but lower than XDR-TB Lower than MDR-TB, but still a significant concern

    Both MDR-TB and XDR-TB are due to the misuse and mismanagement of TB drugs, causing the bacteria to become resistant to the medications. Early and accurate diagnosis is crucial for effective treatment of both MDR-TB and XDR-TB.

    Read more:

    Guilherme Mazui

    Guilherme Mazui is graduated in journalism from the Federal University of Minas Gerais (UFMG) and a master's degree in Communication from the University of São Paulo (USP). In addition, he has experience in advertising writing and has worked as a content editor in several companies.